about
Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjetsTransdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.An overview of clinical and commercial impact of drug delivery systemsTrials and tribulations of skin iontophoresis in therapeuticsSite-specific immunosuppression in vascularized composite allotransplantation: prospects and potentialMicro-scale devices for transdermal drug deliveryIontophoresis of endothelin receptor antagonists in rats and menAn assessment of traditional and novel therapies for cellulite.Emerging strategies for the transdermal delivery of peptide and protein drugs.Transdermal protein delivery by a coadministered peptide identified via phage display.Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats.Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia.Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.Structure-skin permeability relationship of dendrimers.Non-invasive assessment of skin microvascular function in humans: an insight into methods.Development and validation of a HPAE-PAD method for the quantification of CGP69669A, a sialyl Lewis(x) mimetic, in skin permeation studies.Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoringIontophoresis: a potential emergence of a transdermal drug delivery system.Transport numbers in transdermal iontophoresis.Investigation of the mechanisms of action behind Electromotive Drug Administration (EMDA)The endothelium and its role in regulating vascular tonePhysical methods to promote drug delivery on mucosal tissues of the oral cavity.Microemulsions as a surrogate carrier for dermal drug delivery.Pulsed direct and constant direct currents in the pilocarpine iontophoresis sweat chloride test.Transdermal deferoxamine prevents pressure-induced diabetic ulcers.Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial.Evaluation of microvascular reactivity with laser Doppler flowmetry in chronic kidney diseaseA methodological approach to non-invasive assessments of vascular function and morphology.Topically applied phospho-sulindac hydrogel is efficacious and safe in the treatment of experimental arthritis in rats.Topical gene silencing by iontophoretic delivery of an antisense oligonucleotide-dendrimer nanocomplex: the proof of concept in a skin cancer mouse model.Current Methods to Assess Human Cutaneous Blood Flow: An Updated Focus on Laser-Based-Techniques.Iontophoresis Improved Growth Reduction of Invasive Squamous Cell Carcinoma in Topical Photodynamic Therapy.Increasing topical anesthetic efficacy with microneedle application.Local iontophoretic administration of cytotoxic therapies to solid tumorsTransdermal delivery enhanced by magainin pore-forming peptide.Quantitative structure-permeation relationship for iontophoretic transport across the skin.Advances in patient-controlled analgesia: the role of fentanyl ITS.Promotion of the transdermal delivery of protein drugs by N-trimethyl chitosan nanoparticles combined with polypropylene electretFactors of importance for a successful delivery system for proteins.
P2860
Q24674021-A0A9927B-A331-4060-A672-CFBA3AD48D6FQ26778469-4DBA7420-7940-486E-B898-D5DB698C6CFEQ27007143-EDF178B7-B5D9-432A-AD61-AD51B3C9B47DQ27014159-BA5ED061-289F-4C91-ABA1-1CA1A5E33267Q27027795-C570CBA3-7D66-4640-9B5C-406CCC45E248Q27489779-B8F88A49-F2CB-4DD3-9942-5B2DD5F20215Q28727105-4676C2D0-E3E2-41D0-AF47-91E06A4E3291Q33219541-6B137F7E-3EBE-44E7-8C66-4E5063F007F3Q33227495-2A521650-C673-4926-B911-804C799272F5Q33237687-EFDDA63B-27AF-4D7B-994C-9DEC42642F80Q33307491-85B0116F-9238-4528-AE9C-59B7BB440CB5Q33699264-C27E859E-9329-4D96-9E79-D059F481439DQ33708018-39DD2B39-5C53-4019-9166-FC755977577FQ33805053-4E329506-11F8-4A5A-90E9-78189FEC9F77Q33919858-26539F26-6D11-4B2D-8550-006BE6435D20Q34007539-06A3A44A-2AA5-4F61-910E-D8B5475815FEQ34185363-F348A1FA-2A02-400C-94A0-22C12DF75991Q34187741-C973C823-3381-4D7F-B0A1-2D29BBF7C2DDQ34259364-9B192349-F722-4A5C-8575-973A70DA377DQ34481450-38F63D3B-3813-484A-9489-46D67B234321Q34540470-63188499-67B3-4D7C-B068-3455C2C59FE1Q34582309-A51557D6-E5DA-4263-8BFE-4F23F25EBC97Q34784578-E68E9BC3-891B-4BAE-8513-559032BF656BQ34882750-9E3C3000-CB03-4F31-B7D3-3B86CB4408F3Q34915476-2FA86D13-97EC-497F-8CD4-2D2513137E1AQ34926164-35897494-2BEA-4BA2-A679-D01BB23366BCQ35015847-580E894D-2A9D-4DEF-8244-BC4A9CD2B1DCQ35047495-F260BD03-ED3C-4E98-9D99-083D94452441Q35162187-B3EEB0F3-5796-42E9-9BE3-163AEBA504D3Q35388614-F4EE3F39-9314-47CC-A4DF-699FA6EAC476Q35462632-596AE998-D408-454D-B7DC-B895A5014710Q35852836-9391D1BA-F33D-4774-877A-3ED38F6E0A71Q35890731-7A421350-9EA5-41BA-9D3A-3CF2025A1060Q35952252-610558A5-D70F-4BAA-A79A-FE2F8C2A7E68Q35983594-C0CE54A1-22A1-4E52-9935-89F98C550605Q36084340-910C6A36-9A34-4DE0-A627-638E5FD37AE6Q36151555-1CB01512-F8C3-478F-B5F6-3EC3C3D70BC9Q36163764-CD0FDD42-CDF5-4583-9AA7-F369D28509D0Q36185061-E8D24E82-3A90-4F84-9354-B8AE99D6029CQ36316926-0C01F42C-FE5C-45CD-B905-FB2E2B1E116A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Iontophoretic drug delivery.
@ast
Iontophoretic drug delivery.
@en
type
label
Iontophoretic drug delivery.
@ast
Iontophoretic drug delivery.
@en
prefLabel
Iontophoretic drug delivery.
@ast
Iontophoretic drug delivery.
@en
P1476
Iontophoretic drug delivery
@en
P2093
Aarti Naik
James Garrison
P304
P356
10.1016/J.ADDR.2003.10.026
P407
P577
2004-03-01T00:00:00Z